Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00210639 · ClinicalTrials.gov registry record
A Study of Incidence of Musculoskeletal Disorders in Children Who Have Received Levofloxacin or a Standard Non-Fluoroquinolone Therapy for Acute Bacterial Infection
A clinical trial, sponsored by Johnson & Johnson Pharmaceutical Research & Development, L.L.C..
- Completed
- Registry status
- 2,233
- Enrollment target
NCT00210639: Completed study, sponsored by Johnson & Johnson Pharmaceutical Research & Development, L.L.C..
NCT00210639 is a clinical trial that has completed, run by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.. The registered enrollment target is 2,233 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00210639 has completed, sponsored by Johnson & Johnson Pharmaceutical Research & Development, L.L.C..
- COMPLETED
- Registry status
- 2,233 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the long-term safety of levofloxacin administered to children as therapy for acute bacterial infection.
Primary Outcome
The criteria used to assess Musculoskeletal Adverse Event is based on system organ class "Musculoskeletal and connective tissue disorders" of MedDRA 13.0.
Interventions
- DRUG No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,233 participants |
| Start Date | 2002-08 |
| Est. Completion | 2010-05 |
What the finished NCT00210639 record still lists
NCT00210639 is an observational study that tracks outcomes without assigning an intervention. Its 2,233 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT00210639 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00210639 about?
NCT00210639 is a clinical study titled "A Study of Incidence of Musculoskeletal Disorders in Children Who Have Received Levofloxacin or a Standard Non-Fluoroquinolone Therapy for Acute Bacterial Infection". The purpose of this study is to assess the long-term safety of levofloxacin administered to children as therapy for acute bacterial infection.
What is the current status of trial NCT00210639?
This trial is currently completed. The enrollment target is 2,233 participants. The study started on 2002-08. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00210639?
The interventions under investigation include: No intervention (DRUG).
Who is sponsoring clinical trial NCT00210639?
This trial is sponsored by Johnson & Johnson Pharmaceutical Research & Development, L.L.C., which has 102 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06831929 · 2,232 participants · NA
HPV Ends Here: Increasing Uptake of the HPV Vaccine
- NCT06939803 · 2,236 participants · NA
AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.
- NCT04889872 · 2,250 participants · NA
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
- NCT06805513 · 2,250 participants · Phase 3
Actual Use Trial of Tadalafil 5 mg
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia